Randomized Double-Blind, 12-Week Study Of Pregabalin In Subjects With Restless Legs Syndrome.

Trial Profile

Randomized Double-Blind, 12-Week Study Of Pregabalin In Subjects With Restless Legs Syndrome.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 28 Jun 2010

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Restless legs syndrome
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 24 Jun 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 05 May 2010 Planned end date changed from 1 Apr 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.
    • 06 Mar 2010 Planned initiation date changed from 1 Feb 2010 to 1 May 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top